Healthcare
Live Price
Offline$536.59
-2.70% today
1Y Change
+89.67%
Window
Jun 20, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 20, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
United Therapeutics Corporation (UTHR) is a Healthcare stock with a market cap of $25.00B and listed on NASDAQ. The stock last traded around $536.59 and up 89.7% across the available one-year price window (Jun 20, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +10.6%, EPS growth of +14.0%, a dividend yield of 0.0%. What stands out right now is revenue +10.6%, EPS +14.0%, free cash flow -3.7% with operating margin 46.9% and ROIC 15.9%. Valuation sits in the middle of the pack at P/E 18.9 and price/sales 7.9. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines UTHR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UTHR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UTHR Max Drawdown
-10.64%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UTHR and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.